These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


563 related items for PubMed ID: 18676503

  • 1. ADHD subtypes and comorbid anxiety, depression, and oppositional-defiant disorder: differences in sleep problems.
    Mayes SD, Calhoun SL, Bixler EO, Vgontzas AN, Mahr F, Hillwig-Garcia J, Elamir B, Edhere-Ekezie L, Parvin M.
    J Pediatr Psychol; 2009 Apr; 34(3):328-37. PubMed ID: 18676503
    [Abstract] [Full Text] [Related]

  • 2. Sleep problems predict comorbid externalizing behaviors and depression in young adolescents with attention-deficit/hyperactivity disorder.
    Becker SP, Langberg JM, Evans SW.
    Eur Child Adolesc Psychiatry; 2015 Aug; 24(8):897-907. PubMed ID: 25359419
    [Abstract] [Full Text] [Related]

  • 3. The impact of comorbid mental health symptoms and sex on sleep functioning in children with ADHD.
    Becker SP, Cusick CN, Sidol CA, Epstein JN, Tamm L.
    Eur Child Adolesc Psychiatry; 2018 Mar; 27(3):353-365. PubMed ID: 28983772
    [Abstract] [Full Text] [Related]

  • 4. ADHD subtypes and co-occurring anxiety, depression, and oppositional-defiant disorder: differences in Gordon diagnostic system and Wechsler working memory and processing speed index scores.
    Mayes SD, Calhoun SL, Chase GA, Mink DM, Stagg RE.
    J Atten Disord; 2009 May; 12(6):540-50. PubMed ID: 18664713
    [Abstract] [Full Text] [Related]

  • 5. Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorder.
    Goez H, Back-Bennet O, Zelnik N.
    J Child Neurol; 2007 May; 22(5):538-42. PubMed ID: 17690058
    [Abstract] [Full Text] [Related]

  • 6. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
    Dittmann RW, Schacht A, Helsberg K, Schneider-Fresenius C, Lehmann M, Lehmkuhl G, Wehmeier PM.
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):97-110. PubMed ID: 21488751
    [Abstract] [Full Text] [Related]

  • 7. Hot and Cool Executive Functions in Children with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder.
    Antonini TN, Becker SP, Tamm L, Epstein JN.
    J Int Neuropsychol Soc; 2015 Sep; 21(8):584-95. PubMed ID: 26416095
    [Abstract] [Full Text] [Related]

  • 8. Does oppositional defiant disorder have temperament and psychopathological profiles independent of attention deficit/hyperactivity disorder?
    Kim HW, Cho SC, Kim BN, Kim JW, Shin MS, Yeo JY.
    Compr Psychiatry; 2010 Sep; 51(4):412-8. PubMed ID: 20579516
    [Abstract] [Full Text] [Related]

  • 9. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF, Miller A, Fine S.
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [Abstract] [Full Text] [Related]

  • 10. The moderating roles of bedtime activities and anxiety/depression in the relationship between attention-deficit/hyperactivity disorder symptoms and sleep problems in children.
    Tong L, Ye Y, Yan Q.
    BMC Psychiatry; 2018 Sep 17; 18(1):298. PubMed ID: 30236084
    [Abstract] [Full Text] [Related]

  • 11. Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder.
    Hazell P, Zhang S, Wolańczyk T, Barton J, Johnson M, Zuddas A, Danckaerts M, Ladikos A, Benn D, Yoran-Hegesh R, Zeiner P, Michelson D.
    Eur Child Adolesc Psychiatry; 2006 Mar 17; 15(2):105-10. PubMed ID: 16523251
    [Abstract] [Full Text] [Related]

  • 12. Latent class analysis of ADHD and comorbid symptoms in a population sample of adolescent female twins.
    Neuman RJ, Heath A, Reich W, Bucholz KK, Madden PAF, Sun L, Todd RD, Hudziak JJ.
    J Child Psychol Psychiatry; 2001 Oct 17; 42(7):933-42. PubMed ID: 11693588
    [Abstract] [Full Text] [Related]

  • 13. Featured Article: Technology Use and Sleep in Adolescents With and Without Attention-Deficit/Hyperactivity Disorder.
    Bourchtein E, Langberg JM, Cusick CN, Breaux RP, Smith ZR, Becker SP.
    J Pediatr Psychol; 2019 Jun 01; 44(5):517-526. PubMed ID: 30615174
    [Abstract] [Full Text] [Related]

  • 14. Sleep problems predict and are predicted by generalized anxiety/depression and oppositional defiant disorder.
    Shanahan L, Copeland WE, Angold A, Bondy CL, Costello EJ.
    J Am Acad Child Adolesc Psychiatry; 2014 May 01; 53(5):550-8. PubMed ID: 24745954
    [Abstract] [Full Text] [Related]

  • 15. Comorbid problems in ADHD: degree of association, shared endophenotypes, and formation of distinct subtypes. Implications for a future DSM.
    Rommelse NN, Altink ME, Fliers EA, Martin NC, Buschgens CJ, Hartman CA, Buitelaar JK, Faraone SV, Sergeant JA, Oosterlaan J.
    J Abnorm Child Psychol; 2009 Aug 01; 37(6):793-804. PubMed ID: 19308723
    [Abstract] [Full Text] [Related]

  • 16. [Risk factors of attention deficit hyperactivity disorder comorbid with oppositional defiant disorder in children].
    Liu J, Wang YF.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Jun 18; 39(3):257-60. PubMed ID: 17572780
    [Abstract] [Full Text] [Related]

  • 17. The distribution of symptoms of attention-deficit/hyperactivity disorder and oppositional defiant disorder in school age children in Turkey.
    Erşan EE, Doğan O, Doğan S, Sümer H.
    Eur Child Adolesc Psychiatry; 2004 Dec 18; 13(6):354-61. PubMed ID: 15619047
    [Abstract] [Full Text] [Related]

  • 18. Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data.
    Biederman J, Spencer TJ, Newcorn JH, Gao H, Milton DR, Feldman PD, Witte MM.
    Psychopharmacology (Berl); 2007 Jan 18; 190(1):31-41. PubMed ID: 17093981
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and Gender Differences of ODD, Anxiety, and Depression in a Sample of Children With ADHD.
    Mitchison GM, Njardvik U.
    J Atten Disord; 2019 Sep 18; 23(11):1339-1345. PubMed ID: 26443719
    [Abstract] [Full Text] [Related]

  • 20. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.
    Pringsheim T, Hirsch L, Gardner D, Gorman DA.
    Can J Psychiatry; 2015 Feb 18; 60(2):42-51. PubMed ID: 25886655
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.